A COVID-19 vaccine for children under 5 has yet to be authorized, and the Biden administration may now wait until as late as June to do so, Politico reports Thursday, per individuals familiar with the matter.
Health officials had originally hoped to OK the shots at the beginning of the year. But now, regulators are inclined to wait until early summer, worried that authorizing one of the two possible vaccines on a "faster timetable" than the other would confuse the general public and perhaps undermine confidence in the shots' effectiveness, Politico writes, per sources.
Pfizer is likely to hold off on submitting its three-shot regimen for authorization until June, considering the FDA initially "rebuffed" its two-shot regimen for young children. Moderna, however, "plans to formally request authorization for its vaccine for children under six by the end of the month, meaning regulators could conceivably clear it for use by mid-May," Politico writes.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
With those two timetables in mind, the FDA is reportedly worried about "green-lighting Moderna's vaccine, only to potentially find out several weeks later that Pfizer's vaccine performs far better," reports Politico. Such a development could in turn spark backlash from parents who rushed out to get one shot rather than wait for the other, regulators argue.
That scenario doesn't, however, change the potentially worrisome optics of the FDA stalling on a vaccine it expects to authorize.
Plans could still change, sources have cautioned — the pandemic landscape might morph, for one thing, or the increasing pressure on the Biden administration to roll out a regimen could come to a head.
But as it stands, Politico says, the "delays have vexed officials who see the vaccine as key to convincing Americans that the administration has successfully reined in the pandemic."
-
Bluetoothing: the phenomenon driving HIV spike in FijiUnder the Radar ‘Blood-swapping’ between drug users fuelling growing health crisis on Pacific island
-
Marisa Silver’s 6 favorite books that capture a lifetimeFeature The author recommends works by John Williams, Ian McEwan, and more
-
Book reviews: ‘We the People: A History of the U.S. Constitution’ and ‘Will There Ever Be Another You’Feature The many attempts to amend the U.S. Constitution and Patricia Lockwood’s struggle with long Covid
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
